Trials / Completed
CompletedNCT04446312
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bowel Prep | Orally ingested liquid bowel preparation |
Timeline
- Start date
- 2020-07-13
- Primary completion
- 2021-01-07
- Completion
- 2021-02-05
- First posted
- 2020-06-24
- Last updated
- 2023-10-27
- Results posted
- 2023-10-27
Locations
34 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04446312. Inclusion in this directory is not an endorsement.